A transdermal patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. An advantage of a transdermal drug delivery route over other types of medication delivery (such as oral, topical, intravenous, or intramuscular) is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive. The main disadvantage to transdermal delivery systems stems from the fact that the skin is a very effective barrier; as a result, only medications whose molecules are small enough to penetrate the skin can be delivered by this method.
This report contains market size and forecasts of Medical Transdermal Patch in global, including the following market information:
Global Medical Transdermal Patch Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Medical Transdermal Patch Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Medical Transdermal Patch companies in 2021 (%)
The global Medical Transdermal Patch market was valued at US$ million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Methyl Salicylate-based Patch Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Medical Transdermal Patch include Hisamitsu Pharmaceutical, Johnson & Johnson, Novartis, UCB Pharma, Mylan, Teva Pharmaceutical, Nitto Denko, Gr?nenthal and IBSA Group, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Publisher has surveyed the Medical Transdermal Patch manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Medical Transdermal Patch Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Medical Transdermal Patch Market Segment Percentages, by Type, 2021 (%)
Methyl Salicylate-based Patch
Rivastigmine Transdermal Patch
Fentanyl Transdermal Patch
Lidocaine Patch
Diclofenac Patch
Nicotine Transdermal Patch
Others
Global Medical Transdermal Patch Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Medical Transdermal Patch Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Global Medical Transdermal Patch Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Medical Transdermal Patch Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Medical Transdermal Patch revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Medical Transdermal Patch revenues share in global market, 2021 (%)
Key companies Medical Transdermal Patch sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Medical Transdermal Patch sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Hisamitsu Pharmaceutical
Johnson & Johnson
Novartis
UCB Pharma
Mylan
Teva Pharmaceutical
Nitto Denko
Gr?nenthal
IBSA Group
GSK
Luye Pharma Group
Pfizer
Chattem
Dr Reddy's Laboratories
Bayer
Mundipharma
Endo International
Beijing Tide Pharmaceutical
Patch Export, LLC
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Medical Transdermal Patch Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Medical Transdermal Patch Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Medical Transdermal Patch Overall Market Size
2.1 Global Medical Transdermal Patch Market Size: 2021 VS 2028
2.2 Global Medical Transdermal Patch Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Medical Transdermal Patch Sales: 2017-2028
3 Company Landscape
3.1 Top Medical Transdermal Patch Players in Global Market
3.2 Top Global Medical Transdermal Patch Companies Ranked by Revenue
3.3 Global Medical Transdermal Patch Revenue by Companies
3.4 Global Medical Transdermal Patch Sales by Companies
3.5 Global Medical Transdermal Patch Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Medical Transdermal Patch Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Medical Transdermal Patch Product Type
3.8 Tier 1, Tier 2 and Tier 3 Medical Transdermal Patch Players in Global Market
3.8.1 List of Global Tier 1 Medical Transdermal Patch Companies
3.8.2 List of Global Tier 2 and Tier 3 Medical Transdermal Patch Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Medical Transdermal Patch Market Size Markets, 2021 & 2028
4.1.2 Methyl Salicylate-based Patch
4.1.3 Rivastigmine Transdermal Patch
4.1.4 Fentanyl Transdermal Patch
4.1.5 Lidocaine Patch
4.1.6 Diclofenac Patch
4.1.7 Nicotine Transdermal Patch
4.1.8 Others
4.2 By Type - Global Medical Transdermal Patch Revenue & Forecasts
4.2.1 By Type - Global Medical Transdermal Patch Revenue, 2017-2022
4.2.2 By Type - Global Medical Transdermal Patch Revenue, 2023-2028
4.2.3 By Type - Global Medical Transdermal Patch Revenue Market Share, 2017-2028
4.3 By Type - Global Medical Transdermal Patch Sales & Forecasts
4.3.1 By Type - Global Medical Transdermal Patch Sales, 2017-2022
4.3.2 By Type - Global Medical Transdermal Patch Sales, 2023-2028
4.3.3 By Type - Global Medical Transdermal Patch Sales Market Share, 2017-2028
4.4 By Type - Global Medical Transdermal Patch Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Medical Transdermal Patch Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Clinic
5.2 By Application - Global Medical Transdermal Patch Revenue & Forecasts
5.2.1 By Application - Global Medical Transdermal Patch Revenue, 2017-2022
5.2.2 By Application - Global Medical Transdermal Patch Revenue, 2023-2028
5.2.3 By Application - Global Medical Transdermal Patch Revenue Market Share, 2017-2028
5.3 By Application - Global Medical Transdermal Patch Sales & Forecasts
5.3.1 By Application - Global Medical Transdermal Patch Sales, 2017-2022
5.3.2 By Application - Global Medical Transdermal Patch Sales, 2023-2028
5.3.3 By Application - Global Medical Transdermal Patch Sales Market Share, 2017-2028
5.4 By Application - Global Medical Transdermal Patch Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Medical Transdermal Patch Market Size, 2021 & 2028
6.2 By Region - Global Medical Transdermal Patch Revenue & Forecasts
6.2.1 By Region - Global Medical Transdermal Patch Revenue, 2017-2022
6.2.2 By Region - Global Medical Transdermal Patch Revenue, 2023-2028
6.2.3 By Region - Global Medical Transdermal Patch Revenue Market Share, 2017-2028
6.3 By Region - Global Medical Transdermal Patch Sales & Forecasts
6.3.1 By Region - Global Medical Transdermal Patch Sales, 2017-2022
6.3.2 By Region - Global Medical Transdermal Patch Sales, 2023-2028
6.3.3 By Region - Global Medical Transdermal Patch Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Medical Transdermal Patch Revenue, 2017-2028
6.4.2 By Country - North America Medical Transdermal Patch Sales, 2017-2028
6.4.3 US Medical Transdermal Patch Market Size, 2017-2028
6.4.4 Canada Medical Transdermal Patch Market Size, 2017-2028
6.4.5 Mexico Medical Transdermal Patch Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Medical Transdermal Patch Revenue, 2017-2028
6.5.2 By Country - Europe Medical Transdermal Patch Sales, 2017-2028
6.5.3 Germany Medical Transdermal Patch Market Size, 2017-2028
6.5.4 France Medical Transdermal Patch Market Size, 2017-2028
6.5.5 U.K. Medical Transdermal Patch Market Size, 2017-2028
6.5.6 Italy Medical Transdermal Patch Market Size, 2017-2028
6.5.7 Russia Medical Transdermal Patch Market Size, 2017-2028
6.5.8 Nordic Countries Medical Transdermal Patch Market Size, 2017-2028
6.5.9 Benelux Medical Transdermal Patch Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Medical Transdermal Patch Revenue, 2017-2028
6.6.2 By Region - Asia Medical Transdermal Patch Sales, 2017-2028
6.6.3 China Medical Transdermal Patch Market Size, 2017-2028
6.6.4 Japan Medical Transdermal Patch Market Size, 2017-2028
6.6.5 South Korea Medical Transdermal Patch Market Size, 2017-2028
6.6.6 Southeast Asia Medical Transdermal Patch Market Size, 2017-2028
6.6.7 India Medical Transdermal Patch Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Medical Transdermal Patch Revenue, 2017-2028
6.7.2 By Country - South America Medical Transdermal Patch Sales, 2017-2028
6.7.3 Brazil Medical Transdermal Patch Market Size, 2017-2028
6.7.4 Argentina Medical Transdermal Patch Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Medical Transdermal Patch Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Medical Transdermal Patch Sales, 2017-2028
6.8.3 Turkey Medical Transdermal Patch Market Size, 2017-2028
6.8.4 Israel Medical Transdermal Patch Market Size, 2017-2028
6.8.5 Saudi Arabia Medical Transdermal Patch Market Size, 2017-2028
6.8.6 UAE Medical Transdermal Patch Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Hisamitsu Pharmaceutical
7.1.1 Hisamitsu Pharmaceutical Corporate Summary
7.1.2 Hisamitsu Pharmaceutical Business Overview
7.1.3 Hisamitsu Pharmaceutical Medical Transdermal Patch Major Product Offerings
7.1.4 Hisamitsu Pharmaceutical Medical Transdermal Patch Sales and Revenue in Global (2017-2022)
7.1.5 Hisamitsu Pharmaceutical Key News
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Corporate Summary
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson Medical Transdermal Patch Major Product Offerings
7.2.4 Johnson & Johnson Medical Transdermal Patch Sales and Revenue in Global (2017-2022)
7.2.5 Johnson & Johnson Key News
7.3 Novartis
7.3.1 Novartis Corporate Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Medical Transdermal Patch Major Product Offerings
7.3.4 Novartis Medical Transdermal Patch Sales and Revenue in Global (2017-2022)
7.3.5 Novartis Key News
7.4 UCB Pharma
7.4.1 UCB Pharma Corporate Summary
7.4.2 UCB Pharma Business Overview
7.4.3 UCB Pharma Medical Transdermal Patch Major Product Offerings
7.4.4 UCB Pharma Medical Transdermal Patch Sales and Revenue in Global (2017-2022)
7.4.5 UCB Pharma Key News
7.5 Mylan
7.5.1 Mylan Corporate Summary
7.5.2 Mylan Business Overview
7.5.3 Mylan Medical Transdermal Patch Major Product Offerings
7.5.4 Mylan Medical Transdermal Patch Sales and Revenue in Global (2017-2022)
7.5.5 Mylan Key News
7.6 Teva Pharmaceutical
7.6.1 Teva Pharmaceutical Corporate Summary
7.6.2 Teva Pharmaceutical Business Overview
7.6.3 Teva Pharmaceutical Medical Transdermal Patch Major Product Offerings
7.6.4 Teva Pharmaceutical Medical Transdermal Patch Sales and Revenue in Global (2017-2022)
7.6.5 Teva Pharmaceutical Key News
7.7 Nitto Denko
7.7.1 Nitto Denko Corporate Summary
7.7.2 Nitto Denko Business Overview
7.7.3 Nitto Denko Medical Transdermal Patch Major Product Offerings
7.7.4 Nitto Denko Medical Transdermal Patch Sales and Revenue in Global (2017-2022)
7.7.5 Nitto Denko Key News
7.8 Gr
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)